共 50 条
- [4] Intravenous immunoglobulin modulates cutaneous involvement and reduces skin ribrosis in systemic sclerosis: an open-label study ARTHRITIS AND RHEUMATISM, 2004, 50 (03): : 1005 - 1007
- [6] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S524 - S524
- [7] Minocycline is not effective in systemic sclerosis - Results of an open-label multicenter trial ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 553 - 557